KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Operating Income (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 93.07%
Dec 31, 2025 -718.38%
Sep 30, 2025 79.92%
Jun 30, 2025 -2,479.03%
Mar 31, 2025 98.66%
Dec 31, 2024 -261.98%
Sep 30, 2024 35.34%
Jun 30, 2024 86.29%
Mar 31, 2024 -1,249.02%
Dec 31, 2023 -190.24%
Sep 30, 2023 63.72%
Jun 30, 2023 -598.53%
Mar 31, 2023 127.79%
Dec 31, 2022 -409.72%
Sep 30, 2022 81.10%
Jun 30, 2022 2.81%
Mar 31, 2022 -57.43%
Dec 31, 2021 -271.64%
Sep 30, 2021 85.09%
Jun 30, 2021 -189.07%
Mar 31, 2021 97.67%
Dec 31, 2020 -5,353.47%
Sep 30, 2020 77.15%
Jun 30, 2020 72.97%
Mar 31, 2020 -51.32%
Dec 31, 2019 -494.33%
Sep 30, 2019 -125.00%
Jun 30, 2019 -226.45%
Mar 31, 2019 247.62%
Dec 31, 2018 -120.23%
Sep 30, 2018 146.84%
Jun 30, 2018 -668.21%
Mar 31, 2018 121.59%
Dec 31, 2017 -128.03%
Sep 30, 2017 -44.53%
Jun 30, 2017 -139.71%
Mar 31, 2017 315.63%
Dec 31, 2016 -225.98%
Sep 30, 2016 -37.90%
Jun 30, 2016 -32.17%
Mar 31, 2016 144.27%
Dec 31, 2015 -1,138.18%
Sep 30, 2015 88.55%
Jun 30, 2015 -259.90%
Mar 31, 2015 158.58%
Dec 31, 2014 -102,700.00%
Sep 30, 2014 100.18%
Jun 30, 2014 -3,294.12%
Mar 31, 2014 104.21%
Dec 31, 2013 -13.17%
Sep 30, 2013 38.24%
Jun 30, 2013 -48.59%
Mar 31, 2013 30.78%
Dec 31, 2012 74.98%
Sep 30, 2012 -1,107.53%
Jun 30, 2012 -125.69%
Mar 31, 2012 218.94%
Dec 31, 2011 -46.34%
Sep 30, 2011 36.89%
Jun 30, 2011 -27.12%
Mar 31, 2011 42,500.00%
Dec 31, 2010 -100.30%
Sep 30, 2010 6.03%
Jun 30, 2010 115.75%
Mar 31, 2010 229.20%
Dec 31, 2009 -145.56%
Sep 30, 2009 -16.50%
Jun 30, 2009 890.00%